Federico Grossi - 01 Nov 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Medical Officer
Signature
/s/ David Watson, attorney-in-fact for Federico Grossi
Issuer symbol
APLS
Transactions as of
01 Nov 2022
Net transactions value
-$152,075
Form type
4
Filing time
03 Nov 2022, 16:27:02 UTC
Previous filing
05 Oct 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $152,075 -2,500 -2.4% $60.83 99,884 01 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2022.